| Specialty Retail Industry | Consumer Discretionary Sector | Shahe Bagerdjian CEO | OTCQB Exchange | 45972C102 CUSIP |
| US Country | 41 Employees | - Last Dividend | - Last Split | 14 Aug 1997 IPO Date |
International Isotopes Inc. is a company specialized in the manufacture and distribution of products and services for the nuclear medicine, radiopharmaceutical, and industrial applications sectors on a global scale. Established in 1995 and based in Idaho Falls, Idaho, the company extends its offerings across the United States and internationally through four primary segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. Its diverse portfolio ranges from calibration and reference standards for nuclear medicine, cobalt-60 products, to contract manufacturing services for radiopharmaceuticals and radiochemicals. The company positions itself as a key player in its industry by directly selling its products to end-users and distributors, highlighting its commitment to providing specialized and high-quality solutions for its clientele.
The range of products and services offered by International Isotopes Inc. revolves around its expertise in isotopic production and nuclear technology, subdivided into four main segments: